Abstract
Recent studies have indicated that the antitumour effectiveness of electrochemotherapy, a combination of chemotherapeutic drugs with application of high voltage electric pulses applied to the tumour nodule (electroporation), result in a significant reduction in tumour blood flow and may therefore be mediated by an anti-vascular mechanism. The aim of this study was to evaluate the cytotoxicity of electroporation with bleomycin or cisplatin on cultured human microvascular endothelial cells (HMEC-1). The sensitivity of HMEC-1 cells to a 5 min treatment by electroporation with bleomycin or cisplatin (8 electric pulses, pulse duration 100 μs, frequency 1 Hz, electric field intensity 1400 V cm−1) was compared to the sensitivity of cells treated continuously for 3 days with drugs alone. HMEC-1 cells were moderately sensitive to continuous exposure to cisplatin, but showed greater sensitivity to bleomycin. Combination of a 5 min drug exposure with electric pulses increased cytotoxicity of cisplatin by ∼10-fold for cisplatin and ∼5000-fold for bleomycin. The electroporation of HMEC-1 cells with bleomycin for a 5 min exposure was ∼250-fold better than a continuous exposure to the drug alone. The results of this study indicate that the anti-tumour action of electrochemotherapy is likely to be due, in part, to the highly sensitive response of vascular endothelial cells. Further studies are necessary to identify the determinants of endothelial response and its relationship to the anti-vascular action of electrochemotherapy in vivo. © 2001 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Acunas B and Rozanes I (1999) Hepatocellular carcinoma treatment with transcatheter arterial chemoembolization. Eur J Radiol 32(1), 1. 86–89
Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC and Lawley TJ (1992) HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 99: 683–690
Belehradek, Jr J, Orlowski S, Ramirez LH, Pron G, Poddevin B and Mir LM (1994) Electropermeabilization of cells in tissues assessed by the qualitative and quantitative electroloading of bleomycin. Biochim Biophys Acta 1190: 155–163
Cemazar M, Miklavcic D and Sersa G (1998a) Intrinsic sensitivity of tumor cells to bleomycin as an indicator of tumor response to electrochemotherapy. Jpn J Cancer Res 89: 328–333
Cemazar M, Sersa G and Miklavcic D (1998b) Electrochemotherapy with cisplatin in treatment of tumor cell resistant to cisplatin. Anticancer Res 18: 4463–4466
Cemazar M, Jarm T, Miklavc̆ic̆ D, Mac̆ek-Lebar A, Ihan A, Kopitar NA and Sers̆a G (1998c) Effect of electric-field intesity on electropermeabilization and electrosensitivity of various tumor-cell lines in vitro. Electro Magnetobiol 17: 261–270
Cemazar M, Miklavc̆ic̆ D, Scancar J, Dolzan V, Golouh R and Sersa G (1999) Increased platinum accumulation in SA-1 tumor cells after in vivo electrochemotherapy with cisplatin. Br J Cancer 79: 1386–1391
Clements MK, Jones CB, Cumming M and Daoud SS (1999) Antiangiogenic potential of camptothecin and topotecan. Cancer Chemother Pharmacol 44: 411–416
Denekamp J (1990) Vascular attack as a therapeutic strategy for cancer. Cancer Metastasis Rev 9: 267–282
Dirix LY, Libura M, Libura J, Vermeulen PB, Bruijn EA and van Oosterom AT (1997) In vitro toxicity studies with mitomycins and bleomycin on endothelial cells. Anti-Cancer Drugs 8: 859–868
Gilbert RA, Jaroszeski MJ and Heller R (1997) Novel electrode designs for electrochemotherapy. Biochim Biophys Acta 1334: 9–14
Hait WN, Gesmonde JF and Lazo JS (1994) Effect of anti-calmodulin drugs on the growth and sensitivity of C6 rat glioma cells to bleomycin. Anticancer Res 14: 1711–1722
Heller R, Gilbert R and Jaroszeski MJ (2000) Clinical trials of solid tumors using electrochemotherapy. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells, Jaroszeski MJ, Heller R, Gilbert R (eds), pp. 137–156, Humana Press: New Jersey
Kambe M, Arita D, Kikuchi H, Funato T, Tezuka F, Gamo M, Murakawa Y and Kanamaru R (1996) Enhancing the effect of anticancer drugs against the colorectal cancer cell line with electroporation. Tohoku J Exp Med 180: 161–171
Kuriyama S, Matsumoto M, Mitoro A, Tsujinoue H, Toyokawa Y, Nakatani T, Yamazaki M, Okamoto S and Fukui H (1999) Electrochemotherapy against colorectal carcinoma: comparison of in vitro cytotoxicity of 5-fluorouracil, cisplatin and bleomycin. Int J Oncol 15: 89–94
Lazo JS, Braun D, Labaree DC, Schissenbauer JC, Meandzija B, Newman RA and Kennedy KA (1989) Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin. Cancer Res 49: 185–190
Miklavcic D, Beravs K, Semrov D, Cemazar M, Demsar F and Sersa G (1998) The importance of electric field distribution for effective in vivo electroporation of tissues. Biophys J 74: 2152–2158
Mir LM and Orlowski S (2000) The basis of electrochemotherapy. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells, Jaroszeski MJ, Heller R, Gilbert R (eds), pp 99–117, Humana Press: New Jersey
Mir LM, Roth C, Orlowski S, Quintin-Colonna F, Fradelizi D, Belehradek JJr and Kourilsky P (1995) Systemic antitumor effects of electrochemotherapy combined with histoincompatible cells secreting interleukin-2. J Immunother 17: 30–38
Orlowski S, Belehradek J Jr, Paoletti C and Mir LM (1998) Transient electropermeabilization of cells in culture. Increase of the cytotoxicity of anticancer drugs. Biochem Pharmacol 37: 4727–4733
Rols MP and Teissie J (1998) Flow cytometry quantification of electropermeabilization. Methods in molecular biology, Vol 91: Flow cytometry protocols, Jaroszeski MJ, Heller R (eds), pp. 141–147, Humana Press: New Jersey
Sersa G (2000) Electrochemotherapy: animal work review. Electrochemotherapy, electrogenetherapy, and transdermal drug delivery. Electrically mediated delivery of molecules to cells, Jaroszeski MJ, Heller R, Gilbert R (eds), pp 119–136, Humana Press: New Jersey
Sersa G, Cemazar M and Miklavcic D (1995) Antitumor effectiveness of electrochemotherapy with cis-diamminedichloroplatinum (II) in mice. Cancer Res 55: 3450–3455
Sersa G, Miklavcic D, Cemazar M, Belehradek J Jr, Jarm T and Mir LM (1997a) Electrochemotherapy with CDDP on LPB sarcoma: comparison of the anti-tumor effectiveness in immunicompetent and immunodeficient mice. Bioelectroch Bioener 43: 297–283
Sersa G, Cemazar M, Menart V, Gaberc-Porekar V and Miklavcic D (1997b) Antitumor effectiveness of electrochemotherapy is increased by TNF-α on SA-1 tumors in mice. Cancer Letters 116: 85–92
Sersa G, Cemazar M, Parkins CS and Chaplin DJ (1999a) Tumour blood flow changes induced by application of electric pulses. Eur J Cancer 35: 672–677
Sersa G, Cemazar M, Miklavcic D and Chaplin DJ (1999b) Tumor blood flow modifying effect of electrochemotherapy with bleomycin. Anticancer Res 19(5B). 4017–4022
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Cemazar, M., Parkins, C., Holder, A. et al. Electroporation of human microvascular endothelial cells: evidence for an anti-vascular mechanism of electrochemotherapy. Br J Cancer 84, 565–570 (2001). https://doi.org/10.1054/bjoc.2000.1625
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1054/bjoc.2000.1625
Keywords
This article is cited by
-
Characterization of two distinct immortalized endothelial cell lines, EA.hy926 and HMEC-1, for in vitro studies: exploring the impact of calcium electroporation, Ca2+ signaling and transcriptomic profiles
Cell Communication and Signaling (2024)
-
Cytoskeletal Remodeling and Gap Junction Translocation Mediates Blood–Brain Barrier Disruption by Non-invasive Low-Voltage Pulsed Electric Fields
Annals of Biomedical Engineering (2024)
-
Treatment of cervical cancer by electrochemotherapy with bleomycin, cisplatin, and calcium: an in vitro experimental study
Medical Oncology (2022)
-
Electrochemotherapy of skin metastases from breast cancer: a systematic review
Clinical & Experimental Metastasis (2021)
-
Large Liver Blood Vessels and Bile Ducts Are Not Damaged by Electrochemotherapy with Bleomycin in Pigs
Scientific Reports (2019)